Cofinimmo Future Growth

Future criteria checks 3/6

Cofinimmo is forecast to grow earnings and revenue by 79.4% and 0.03% per annum respectively. EPS is expected to grow by 72% per annum. Return on equity is forecast to be 6.9% in 3 years.

Key information

79.4%

Earnings growth rate

72.0%

EPS growth rate

Health Care REITs earnings growth	42.6%
Revenue growth rate	0.03%
Future return on equity	6.9%
Analyst coverage	Good
Last updated	30 Oct 2024

Recent future growth updates

Recent updates

Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return

Feb 11

Is Cofinimmo SA's (EBR:COFB) Recent Price Movement Underpinned By Its Weak Fundamentals?

Dec 21

Earnings and Revenue Growth Forecasts

ENXTBR:COFB - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	367	291	237	N/A	9
12/31/2025	358	278	224	N/A	9
12/31/2024	351	106	332	N/A	9
9/30/2024	392	-52	N/A	N/A	N/A
6/30/2024	392	-41	254	255	N/A
3/31/2024	391	-55	N/A	N/A	N/A
12/31/2023	389	-55	227	228	N/A
9/30/2023	379	49	N/A	N/A	N/A
6/30/2023	379	185	223	224	N/A
3/31/2023	373	333	N/A	N/A	N/A
12/31/2022	368	483	209	210	N/A
9/30/2022	367	565	N/A	N/A	N/A
6/30/2022	357	489	205	206	N/A
3/31/2022	351	382	N/A	N/A	N/A
12/31/2021	343	260	199	200	N/A
9/30/2021	328	189	N/A	N/A	N/A
6/30/2021	312	155	185	186	N/A
3/31/2021	276	122	N/A	N/A	N/A
12/31/2020	293	119	178	180	N/A
9/30/2020	296	170	N/A	N/A	N/A
6/30/2020	266	193	166	167	N/A
3/31/2020	292	222	N/A	N/A	N/A
12/31/2019	285	205	169	169	N/A
9/30/2019	241	134	N/A	N/A	N/A
6/30/2019	270	119	182	182	N/A
3/31/2019	259	105	N/A	N/A	N/A
12/31/2018	263	146	160	161	N/A
9/30/2018	260	186	N/A	N/A	N/A
6/30/2018	258	170	N/A	140	N/A
3/31/2018	264	166	N/A	N/A	N/A
12/31/2017	263	137	N/A	157	N/A
9/30/2017	267	121	N/A	N/A	N/A
6/30/2017	267	128	N/A	168	N/A
3/31/2017	275	134	N/A	N/A	N/A
12/31/2016	257	97	N/A	144	N/A
9/30/2016	253	100	N/A	N/A	N/A
6/30/2016	255	82	N/A	148	N/A
3/31/2016	249	110	N/A	N/A	N/A
12/31/2015	255	104	N/A	170	N/A
9/30/2015	260	76	N/A	N/A	N/A
6/30/2015	262	66	N/A	158	N/A
3/31/2015	264	-59	N/A	N/A	N/A
12/31/2014	259	-53	N/A	149	N/A
9/30/2014	270	-51	N/A	N/A	N/A
6/30/2014	274	-39	N/A	150	N/A
3/31/2014	276	37	N/A	N/A	N/A
12/31/2013	273	59	N/A	153	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COFB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).

Earnings vs Market: COFB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: COFB is expected to become profitable in the next 3 years.

Revenue vs Market: COFB's revenue (0.03% per year) is forecast to grow slower than the Belgian market (7.4% per year).

High Growth Revenue: COFB's revenue (0.03% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COFB's Return on Equity is forecast to be low in 3 years time (6.9%).

Cofinimmo Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 23%

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 31%

Consensus EPS estimates fall by 16%, revenue upgraded

Consensus EPS estimates fall by 26%, revenue upgraded

Consensus EPS estimates fall by 10%

Recent updates

Third quarter 2024 earnings: Revenues exceed analyst expectations

Second quarter 2024 earnings released

Cofinimmo SA to Report Q3, 2025 Results on Oct 31, 2025

Dividend of €4.34 announced

First quarter 2024 earnings released: EPS: €0.48 (vs €0.53 in 1Q 2023)

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 23%

Now 21% undervalued

Now 20% undervalued

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 31%

Cofinimmo SA to Report First Half, 2024 Results on Jul 26, 2024

Third quarter 2023 earnings released: EPS: €0.34 (vs €4.60 in 3Q 2022)

Cofinimmo SA, Annual General Meeting, May 08, 2024

Consensus EPS estimates fall by 16%, revenue upgraded

Cofinimmo SA has completed a Follow-on Equity Offering in the amount of €167.1483 million.

An unknown buyer signed a private agreement to acquire Two Nursing And Care Homes In Belgium from Cofinimmo SA (ENXTBR:COFB) for €31 million.

An unknown buyer signed a private agreement to acquire Two Nursing And Care Homes In Belgium from Cofinimmo SA (ENXTBR:COFB) for €31 million.

Consensus EPS estimates fall by 26%, revenue upgraded

Second quarter 2023 earnings released

New minor risk - Dividend sustainability

Cofinimmo SA (ENXTBR:COFB) acquired The Park Nursing Home for € 7.35 million.

Consensus EPS estimates fall by 10%

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Upcoming dividend of €4.34 per share at 7.2% yield

Full year 2022 earnings: EPS exceeds analyst expectations

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Full year 2022 earnings: EPS exceeds analyst expectations

Price target decreased to €114

Consensus EPS estimates increase by 14%

Third quarter 2022 earnings: Revenues miss analyst expectations

Cofinimmo SA acquired Four nursing homes in Germany.

Cofinimmo SA (ENXTBR:COFB) signed agreement to acquire Four Nursing And Care Homes In Germany for €61 million.

Cofinimmo SA (ENXTBR:COFB) acquired Four Nursing And Care Homes In Germany for €61 million.

Cofinimmo SA (ENXTBR:COFB) acquired Nursing And Care Home In Netherlands for approximately €12 million.

Second quarter 2022 earnings: Revenues miss analyst expectations

Cofinimmo SA to Report Fiscal Year 2022 Final Results on Apr 07, 2023

Cofinimmo SA (ENXTBR:COFB) acquired Medical office building in Vlaardingen for €5 million.

Insufficient new directors

Upcoming dividend of €4.20 per share

First quarter 2022 earnings: Revenues miss analyst expectations

Insufficient new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Full year 2021 earnings: EPS and revenues miss analyst expectations

Cofinimmo SA (ENXTBR:COFB) acquired Nursing and care home in Charleroi for €18 million.

Cofinimmo SA (ENXTBR:COFB) acquired Nursing and Care Home in Chanteloup-les-Vignes.

Third quarter 2021 earnings released: EPS €2.44 (vs €1.45 in 3Q 2020)

Cofinimmo SA (ENXTBR:COFB) acquired Nursing and Care Home in Fontainebleau, South-east of Paris from Promoval Partenaires.

Cofinimmo SA (ENXTBR:COFB) acquired Three recent nursing and care homes in England for approximately £57 million.

Cofinimmo SA (ENXTBR:COFB) acquired New nursing and care home in Bilbao, Spain for €9 million.

Cofinimmo SA (ENXTBR:COFB) acquired 95% stake in Celenus Klinik an der Salza.

Brody Projectontwikkeling & Investeringen acquired office buildings located in Antwerp and Brussels from Cofinimmo SA (ENXTBR:COFB) for approximately €80 million.

Cofinimmo SA (ENXTBR:COFB) signed an agreement to acquire Nursing and Care Home in Leipzig, Germany for approximately €19 million.

Upcoming dividend of €4.06 per share

First quarter 2021 earnings released: EPS €1.67 (vs €1.64 in 1Q 2020)

Full year 2020 earnings released: EPS €4.50 (vs €8.37 in FY 2019)

Consensus forecasts updated

Full year 2020 earnings released: EPS €4.50 (vs €8.37 in FY 2019)

Revenue beats expectations, earnings disappoint

Analysts lower EPS estimates to €6.59

Cofinimmo SA to Report Q3, 2021 Results on Oct 27, 2021

Shareholders Of Cofinimmo (EBR:COFB) Must Be Happy With Their 64% Return

New 90-day high: €130

Cofinimmo SA (ENXTBR:COFB) acquired a nursing and care Home Under Construction in Vantaa from Fincap KiinteistOkehitys Oy for €12 million.

Cofinimmo SA (ENXTBR:COFB) acquired Six nursing and care homes and one rehabilitation clinic in Ireland for €93 million.